Abstract
The release of holocytochrome c (cyt c) from mitochondria into the cytosol is reportedly a landmark of the execution phase of apoptosis. As shown here, the P-glycoprotein- (P-gp) expressing K562/ADR cell line (but not the parental K562 cell line) exhibits both cytosolic and mitochondrial cyt c in the absence of any signs of apoptosis. K562/ADR cells were found to be relatively resistant to a variety of different inducers of apoptosis, and blocking the P-gp did not reverse this resistance. The release of cyt c in non-apoptotic K562/ADR cells was not accompanied by that of any other mitochondrial apoptogenic protein, such as AIF or Smac/DIABLO, and was inhibited by Bcl-2 over expression. In addition, using a cell-free system, we show that mitochondria isolated from K562/ADR cells spontaneously released cyt c. These data suggest that cyt c release may be compatible with the preservation of mitochondrial integrity and function, as well as cell proliferation.
Similar content being viewed by others
Abbreviations
- Ac-DEVD-AMC:
-
acetyl-Asp-Glu-Val-Asp-7-amido-4-methylcoumarin
- Ac-LEHD-AMC:
-
acetyl-Leu-Glu-His-Asp-7-amido-4-methylcoumarin
- BSA:
-
bovine serum albumin
- ANT:
-
Adenine Nucleotide Transporter
- apo-cyt c:
-
apocytochrome c
- cyt c:
-
holocytochrome c
- DTT:
-
dithiothreitol
- MDR:
-
multidrug resistance
- PBS:
-
phosphate buffered saline
- P-gp:
-
P-glycoprotein
- PTP:
-
mitochondrial permeability transition pore
- SDS-PAGE:
-
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
- VDAC:
-
Voltage Dependent Anionic Channel
- XIAP:
-
X-chromosome-linked inhibitor of apoptosis protein
References
Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001; 411: 342–348.
Zamzami N, Kroemer G. The mitochondrion in apoptosis: How Pandor’s box opens. Nature Reviews Molecular Cell Biology 2001; 2: 67–71.
Adams JM. Ways of dying: Multiple pathways to apoptosis. Genes Dev. 2003; 17: 2481–2495.
Martinou J, Green D. Breaking the mitochondrial barrier. Nature Reviews Molecular Cell Biology 2001; 2: 63–67.
von Ahsen O, Renken C, Perkins G, Kluck RM, Bossy-Wetzel E, Newmeyer DD. preservation of mitochondrial structure and function after bid- or bax-mediated cytochrome c release. J. Cell Biol. 2000; 150: 1027–1036.
Von Ahsen O, Waterhouse NJ, Kuwana T, Newmeyer DD, Green DR. The ‘harmless’ release of cytochrome c. Cell Death Differ 2000; 7: 1192–1199.
Mayer A, Neupert W, Lill R. Translocation of apocytochrome c across the outer membrane of mitochondria. J Biol Chem 1995; 270: 12390–12397.
Pommier Y, Sordet O, Antony S, Hayward RL, Kohn KW. Apoptosis defects and chemotherapy resistance: Molecular interaction maps and networks. Oncogene 2004; 23: 2934–2949.
Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: A link between cancer genetics and chemotherapy. Cell 2002; 108: 153–164.
Chauncey T. Drug resistance mechanisms in acute leukemia. Curr Opin Oncol 2001; 13: 21–26.
Marie JP. Drug resistance in hematologic malignancies. Curr Opin Oncol 2001; 13: 463–469.
Johnstone RW, Ruefli AA, Smyth MJ. Multiple physiological functions for multidrug transporter P-glycoprotein? Trends Biochem Sci 2000; 25: 1–6.
Oliver L, Priault M, Tremblais K, et al. The substitution of the C-terminus of bax by that of bcl-xL does not affect its subcellular localization but abrogates its pro-apoptotic properties. FEBS Lett 2000; 487: 161–165.
Juin P, Tremblais K, LeCabellec MT, Gregoire M, Meflah K, Vallette FM. Potentiation of apoptosis by mitochondria in a cell-free system. Biochem Biophys Res Commun 1998; 253: 185–191.
Jemmerson R, Liu J, Hausauer D, Lam KP, Mondino A, Nelson RD. A conformational change in cytochrome c of apoptotic and necrotic cells is detected by monoclonal antibody binding and mimicked by association of the native antigen with synthetic phospholipid vesicles. Biochemistry 1999; 38: 3599–3609.
Bernardi P, Petronilli V, Di Lisa F, Forte M. A mitochondrial perspective on cell death. Trends Biochem Sci 2001; 26: 112–117.
Liu FT, Goff LK, Hao JH, Newland AC, Jia L. Increase in the ratio of mitochondrial Bax/Bcl-XL induces Bax activation in human leukemic K562 cell line. Apoptosis 2004; 9: 377–384.
Adams JM, Cory S. Apoptosomes: Engines for caspase activation. Curr Opin Cell Biol 2002; 14: 715–720.
Varghese J, Khandre NS, Sarin A. Caspase-3 activation is an early event and initiates apoptotic damage in a human leukemia cell line. Apoptosis 2003; 8: 363–370.
Juin P, Pelletier M, Oliver L, et al. Induction of a caspase-3-like activity by calcium in normal cytosolic extracts triggers nuclear apoptosis in a cell-free system. J Biol Chem 1998; 273: 17559–17564.
Johnson CR, Jarvis WD. Caspase-9 regulation: An update. Apoptosis 2004; 9: 423–427.
Jia L, Patwari Y, Kelsey SM, et al. Role of Smac in human leukaemic cell apoptosis and proliferation. Oncogene 2003; 22: 1589–1599.
Jia L, Srinivasula SM, Liu FT, et al. Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells. Blood 2001; 98: 414–421.
Wolf BB, Schuler M, Li W, et al. Defective cytochrome c-dependent caspase activation in ovarian cancer cell lines due to diminished or absent apoptotic protease activating factor-1 activity. J Biol Chem 2001; 276: 34244–34251.
Adams JM, Cory S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 2001; 26: 61–66.
Yanovich S, Hall RE, Gewirtz DA. Characterization of a K562 multidrug-resistant cell line. Cancer Res 1989; 49: 4499–4503.
Chauhan D, Hideshima T, Rosen S, Reed JC, Kharbanda S, Anderson KC. Apaf-1/cytochrome c-independent and Smac-dependent induction of apoptosis in multiple myeloma (MM) cells. J Biol Chem 2001; 276: 24453–24456.
Ferri KF, Jacotot E, Blanco J, et al. Apoptosis control in syncytia induced by the HIV type 1-envelope glycoprotein complex: Role of mitochondria and caspases. J Exp Med 2000; 192: 1081–1092.
Chen Q, Takeyama N, Brady G, Watson AJ, Dive C. Blood cells with reduced mitochondrial membrane potential and cytosolic cytochrome C can survive and maintain clonogenicity given appropriate signals to suppress apoptosis. Blood 1998; 92: 4545–4553.
Campone M, Vavasseur F, Le Cabellec MT, Meflah K, Vallette FM, Oliver L. Induction of chemoresistance in HL-60 cells concomitantly causes a resistance to apoptosis and the synthesis of P-glycoprotein. Leukemia 2001; 15: 1377–1387.
Pelletier M, Cartron PF, Delaval F, Meflah K, Vallette FM, Oliver L. Caspase 3 activation is controlled by a sequence located in the N-terminus of its large subunit. Biochem Biophys Res Commun 2004; 316: 93–99.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Oliver, L., LeCabellec, MT., Pradal, G. et al. Constitutive presence of cytochrome c in the cytosol of a chemoresistant leukemic cell line. Apoptosis 10, 277–287 (2005). https://doi.org/10.1007/s10495-005-0802-x
Issue Date:
DOI: https://doi.org/10.1007/s10495-005-0802-x